SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001725160-22-000017
Filing Date
2022-02-03
Accepted
2022-02-03 20:03:41
Documents
1
Period of Report
2022-02-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_164393660436349.html 4  
1 FORM 4 wf-form4_164393660436349.xml 4 16577
  Complete submission text file 0001725160-22-000017.txt   18117
Mailing Address C/O AISLING CAPITAL 888 SEVENTH AVENUE, 30TH FLOOR NEW YORK NY 10106
Business Address
SUN ANTHONY Y (Reporting) CIK: 0001377952 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39263 | Film No.: 22590455

Mailing Address 1359 BROADWAY, SUITE 1710 NEW YORK NY 10018
Business Address 1359 BROADWAY, SUITE 1710 NEW YORK NY 10018 (212) 433-3791
Zentalis Pharmaceuticals, Inc. (Issuer) CIK: 0001725160 (see all company filings)

IRS No.: 823607803 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations